期刊文献+

成人先天性心脏病合并重度肺动脉高压的围术期及中长期药物治疗观察 被引量:11

The peri-operative observation and mid-long term follow-up of pharmaceutic therapy in the adults of congenital heart disease combined with severe pulmonary hypertension
下载PDF
导出
摘要 目的观察成人先天性心脏病合并重度肺动脉高压围手术期及中长期联合药物治疗效果,探讨其治疗规范。方法 68例成人先天性心脏病合并重度肺动脉高压患者通过围手术期应用联合药物控制肺动脉压力并确定根治手术指征后,均在体外循环下进行根治手术,手术前、后对患者肺动脉压力进行监测并根据监测结果给予西地那非、前列地尔、NO吸入以及血管紧张素转化酶抑制剂(ACEI)、血管紧张素受体阻断剂(ARB)、钙离子拮抗剂等多种药物联合应用治疗方案,并对患者进行长期随访观察治疗效果。结果手术死亡1例,围手术期肺动脉高压危象6例均经治疗好转出院,除少数患者肺动脉压力反弹性升高外,多数患者经围手术期和长期不间断药物治疗后肺动脉压力控制满意,手术后中长期治疗效果良好。结论围术期和术后中长期多种药物联合应用治疗方案,对于降低成人先天性心脏病合并重度肺动脉高压患者围术期死亡率和维持远期良好治疗效果具有重要意义。 Objective To study the effects of peri -operative and mid -long term pharmaceutic therapy to the adults of congenital heart disease (CHD) combined with severe pulmonary hypertension (PH) and explore the standard protocol of drug treatment to these patients. Methods 68 adult CHD patients with severe PH were treated with combined pharmaceutic therapy in peri - opretation, including with sildenafil, alprostadil, NO inhalation, angiotensin -converting enzyme inhibitor (ACEI), angiotensin receptor blocking agent, calcium ion antagon and so on. All the patients were accomplished corrected operation with extracorpereal circulation. Then the pulmonary pressure and the effects of combined pharmaceutic therapy were continuously monitored. Results There was only one patients died after operation. Six patients have the complication of pulmonary hypertensive crisis after operation and went smoothly by given drugs and corresponding therapy. Most of the patients had good results through peri - operation and mid - long term treatments by follow - up and PH monitoring. Conclutdon The peri - operative and mid - long term pharmaceutic therapy to the adults of CHD combined with severe PH has significant results in reducing the pefi -operative mortality and maintenance the long term operative therapeutic efficacy.
出处 《中国体外循环杂志》 2012年第3期158-161,共4页 Chinese Journal of Extracorporeal Circulation
关键词 成人 先天性心脏病 肺动脉高压 药物治疗 Adult patients Congenital heart disease Pulmonary hypertension Pharmaceutic therapy
  • 相关文献

参考文献11

  • 1Galie N, Manes A, Palazzini M, et al. Management of pulmo nary arterial hypertension associated with congenital systemic to pulmonary shunts and Eisenmengerls syndrome [ J]. Drugs , 2008, 68 (8) : 1049 1066.
  • 2李强强,顾虹,罗毅.先天性心脏病合并肺动脉高压的药物治疗进展[J].心肺血管病杂志,2009,28(3):212-214. 被引量:28
  • 3黄智伟,吴炳祥.肺动脉高压联合药物治疗的研究进展[J].心血管病学进展,2009,30(1):109-111. 被引量:4
  • 4Ivy DD, Doran AK, Smith KJ, et al. Short and long term effects of inhaled therapy in children with pulmonary arterial hyperten sion [J]. J Am Coil Cardiol ,2008, 51(2) :161 169.
  • 5Piamsomboon C, TanakaKA, Szlam F, et al. Comparison of re laxation responses tomultiple vasodilators inTxA (2) analog and endothelin 1 preeontraeted pulmonary arteries [ J ]. Aeta An aesthesiol Seand, 2007, 51 (6) : 714 721.
  • 6高宇翔,卿恩明,欧阳川,毛斌,谭群.前列腺素E_1不同给药时机治疗围术期先天性心脏病肺动脉高压的观察[J].中华麻醉学杂志,1999,19(6):340-342. 被引量:9
  • 7Aoe M, Trachiotis GD, Okabayashi K, et al. Administration of prostaglandin E1 after lung transplantation improves early graft function [ J ]. Ann Thorac Surg, 1994,58 (3) :655 661.
  • 8Shen J,He B,Wang B. Effects of lipo prostaglandin E1 on pul monary hemodynamics and clinical outcomes in patients with pul monary arterial hypertension [ J]. Chest, 2005, 128 (2) : 714 719.
  • 9徐卓明,苏肇伉,陈玲,史珍英,俞晓青,蔡及明.先天性心脏病术后肺动脉高压的一氧化氮吸入治疗[J].中华胸心血管外科杂志,2001,17(2):74-76. 被引量:18
  • 10Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension [J]. N Engl J Med, 2004, 351 (14) : 1425 1428.

二级参考文献36

  • 1Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
  • 2冯俊波,刘建新.前列腺素E1与雾化吸入硝酸甘油在先天性心脏病重度肺动脉高压治疗中的应用探讨[J].中国医师杂志,2007,9(3):415-416. 被引量:1
  • 3周其文 薛淦兴.先天性心脏病并发重度肺动脉高压的手术指征143例临床分析[J].中国循环杂志,1987,2:390-392.
  • 4Galie N ,Humbert M ,Vachiery JL ,et al. Effects of heraprost sodium ,an oral prostacyclin analogue,in patients with pulmonary, arterial hypertension:a randomized, double-blind, placebo-controlled trial [ J ]. J Am Coll Cardiol,2002,39 (9) : 1496-1502.
  • 5Olschewski H, Simonneau G, Galie N, et al. Inhaled ilopmst for severe pulmonary hypertension [ J ]. N Engl J Med ,2002,347 ( 5 ) :322-329.
  • 6Simonneau G,Barst RJ,Galie N,et al. Continuous subcutaneous infusion of treprostinil,a prostacyclin analogue,in patients with pulmonary arterial hypertension : a double-blind, randomized, placebo-controlled trial [ J ]. Am J Respir Crit Care Med,2002,165 (6) :800-804.
  • 7McLaughlin VV ,Sitbon O ,Badesch DB ,et al. Survival with first-line bosentan in patients with primary pulmonary hypertension [ J ]. Eur Respir J,2005,25 (2) : 244 -249.
  • 8Sastry BK,Narasimhan C,Reddy NK,et al. Clinical efficacy of sildenafil in primary pulmonary hypertension : a randomized, placebo-controlled, double-blind, crossover study [ J ]. J Am Coll Cardiol,2004,43 ( 7 ) : 1149-1153.
  • 9Onen ZP, Akkoca Yildiz O,Eris Gulbay B, et al. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension[J]. Tuberkulozve Toraks Dergisi,2006,54(2):177-181.
  • 10Bhatia S,Frantz RP,Severson C J, et al. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy[ J]. Mayo Clin Proc ,2003,78 (10) :1207-1213.

共引文献54

同被引文献87

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部